Fasting Bioavailability Study of Lovastatin Tablets and Mevacor Tablets

Phase 1 Completed 54 enrolled Mutual Pharmaceutical Company, Inc.

RandomizedCrossoverSingle-blind

Summary

The purpose of this study is to evaluate and compare the relative bioavailability and therefore the bioequivalence of a test formulation of lovastatin tablets to an equivalent dose of Mevacor® tablets after a single oral dose administered under fasting conditions.

Timeline

Start: 2004-09
Primary completion: 2004-10
Completion: 2004-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lovastatin	Small molecule	40 mg	Oral

Indications

No indication recorded.